Translational Colorectal Cancer: From Genomics to Therapy

1. Implement genetic testing of patients and family members to screen for those who are at risk for developing pancreatic cancer and other cancers.
2. Evaluate, counsel and treat patients with pancreatic cancer at all stages of disease (locally advanced, resectable, borderline resectable, metastatic).
3. Provide a comprehensive understanding of innovative and emerging cancer therapies, inclusive of the side effects, to the cancer patient.
4. Apprise healthcare providers of emerging paradigms in latest clinical trials and supportive care.

Course via Web Streaming - Live Webcast to be hosted in Central Daylight Time (CDT)

Translational Colorectal Cancer: from Genomics to Therapy will be held on Thursday, March 4, 2021 will begin for registrants at 8:30 a.m. ET, and will adjourn at 12:00 pm ET on Friday, March 5, 2021.

SEE AGENDA FOR TIMES

This program will be presented only as a live streaming course. You will receive an email from the course planner with login and access to the live online course approximately a week before the conference.

 The virtual conference registration includes access to on-line education materials.

The Department of Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the Department of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

The Department of Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

John Paul Shen, MD
Assistant Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Activity Co-Director, Faculty

Nothing to disclose

Xiling Shen, PhD
Hawkins Family Associate Professor
Duke University

Activity Co-Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Xilis Inc. AccuBeing Inc.

Edmund S. Kopetz, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Activity Director, Faculty

Consulting or Advisory Role-Roche-|Consulting or Advisory Role-Genentech, Inc.-|Consulting or Advisory Role-EMD Serono-|Consulting or Advisory Role-Merck and Company, Inc.-|Consulting or Advisory Role-Karyopharm Therapeutics-|Consulting or Advisory Role-Amal Therapeutics-|Consulting or Advisory Role-Navire Pharma-|Consulting or Advisory Role-Symphogen-|Consulting or Advisory Role-Holy Stone-|Consulting or Advisory Role-Biocartis-|Consulting or Advisory Role-Amgen-|Consulting or Advisory Role-Novartis AG-|Consulting or Advisory Role-Lilly-|Consulting or Advisory Role-Boehringer Ingelheim-|Consulting or Advisory Role-Boston Biomedical-|Consulting or Advisory Role-AstraZeneca/MedImmune-|Consulting or Advisory Role-Bayer Health-|Consulting or Advisory Role-Pierre Fabre-|Consulting or Advisory Role-Redx Pharma-

monica bertagnolli, MD
DFCI/BWH

Faculty

Grant or research support-AbbVie|Grant or research support-Agenus|Grant or research support-AstraZeneca|Grant or research support-Astellas|Grant or research support-Baxalta|Grant or research support-Bayer Corporation|Grant or research support-Breast Cancer Research Foundation|Grant or research support-Bristol-Myers Squib Aventis|Grant or research support-Celgene|Grant or research support-Chinese Medical Education Association|Grant or research support-Complion|Grant or research support-Czarnowski|Grant or research support-Derse, Inc|Grant or research support-Eisai, Inc.|Grant or research support-Exelixis|Grant or research support-Genentech, Inc.|Grant or research support-GHI|Grant or research support-Gilead Sciences|Grant or research support-GSK Total|Grant or research support-Incyte Corporation|Grant or research support-Janssen|Grant or research support-Jazz Pharma|Grant or research support-Leidos|Grant or research support-Lexicon Pharma|Grant or research support-Eli Lilly and Company|Grant or research support-Maltrex|Grant or research support-Merck and Company, Inc.|Grant or research support-MITRE Corporation|Grant or research support-Millennium Pharmaceuticals, Inc.|Grant or research support-Novartis AG|Grant or research support-Pfizer, Inc.|Grant or research support-Pharmacyclics|Grant or research support-Robert Wood Johnson Foundation|Grant or research support-Roche/Genentech|Grant or research support-Sagerock Advisors|Grant or research support-Sanofi-Aventis|Grant or research support-Servier Affaires Medicales|Grant or research support-STO|Grant or research support-Taiho Oncology|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Tesaro|Grant or research support-TEVA|Membership on advisory committees or review panels, board membership, etc.-Natera, Inc.|Membership on advisory committees or review panels, board membership, etc.-Leap Therapeutics

George J. Chang, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Paid consultant-Other-Medicaroid|Membership on advisory committees or review panels, board membership, etc.-Other-Exact Sciences|Membership on advisory committees or review panels, board membership, etc.-Johnson and Johnson

Christina Curtis, PhD
Associate Professor
Stanford University

Faculty

Consulting Fee-Genentech, Inc.|Stocks or stock options, excluding diversified mutual funds-GRAIL Inc|Consulting Fee-NanoString Inc|Grant or research support-National Institutes of Health

Luis Diaz, MD
Head, Division of Solid Tumor Oncology
Memorial Sloan Kettering Cancer Center

Faculty

Membership on advisory committees or review panels, board membership, etc.-Other-Personal Genome Diagnostics (PGDx)|Paid consultant-Other-Personal Genome Diagnostics (PGDx)|Stocks or stock options, excluding diversified mutual funds-Other-Personal Genome Diagnostics (PGDx)|Membership on advisory committees or review panels, board membership, etc.-Other-Jounce Therapeutics|Stocks or stock options, excluding diversified mutual funds-Other-Jounce Therapeutics|Paid consultant-Other-4 Paws (PetDx)|Stocks or stock options, excluding diversified mutual funds-Other-4 Paws (PetDx)|Paid consultant-Other-Innovatus CP|Paid consultant-Other-Se'er|Stocks or stock options, excluding diversified mutual funds-Other-Se'er|Paid consultant-Other-Kinnate|Stocks or stock options, excluding diversified mutual funds-Other-Kinnate|Paid consultant-Other-Neophore|Grant or research support-Merck and Company, Inc.|Other-Uncompensated consultant-Merck and Company, Inc.|Stocks or stock options, excluding diversified mutual funds-Other-Thrive Early Detection|Stocks or stock options, excluding diversified mutual funds-Other-Amgen

Eric R Fearon, MD, PhD
Emanuel N. Maisel Professor of Oncology, Director, University of Michigan Rogel Cancer Center
University of Michigan

Faculty

Nothing to disclose

Matan Hofree, PhD
Postdoctoral Associate
Broad Institute
Israel

Faculty

Nothing to disclose

Sanford Markowitz, MD, PhD
Case Western Reserve University

Faculty

Other-Founder, Consultant, Board Member, Sponsored Research, Royalty Interest, Stock/Option Holder-Other-Rodeo Therapeutics|Other-Founder, Consultant, Board Member, Sponsored Research, Royalty Interest, Stock/Option Holder-Other-Lucid Diagnostics|Other-Consultant and Option Shares-Other-Summit Biolabs|Other-Consultant, Stock Options-Other-Summit Biolabs

Zsofia Stadler, MD
MSKCC

Faculty

Nothing to disclose

Eduardo Vilar Sanchez, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Grant or research support-Johnson and Johnson|Consulting Fee-Johnson and Johnson|Consulting Fee-Other-Recursion Pharma

Yi Qian You, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Nastaran Zahir, DVM,PhD
Associate Director
National Cancer Institute

Faculty

Nothing to disclose

Emina Huang, MD, MBA, FACS, FASCRS
Cleveland Clinic

Faculty, Other Planning Committee Member

Nothing to disclose

Steven M Lipkin, MD, PhD, Professor
Dr
Weill Cornell

Faculty, Other Planning Committee Member

Nothing to disclose

Wenyi Wang, PhD
Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Zhenghe Wang, PhD
Professor
Case Western Reserve University

Faculty, Other Planning Committee Member

Nothing to disclose